With over 12 years’ experience supporting the use of digital health technologies in drug development studies and clinical research. I have spent these years not only evangelizing the value and benefit of digital endpoints derived from digital health technologies but also supporting multi-stakeholder teams successfully implement these technologies in trials. I am passionate about ensuring that the patient voice is not lost in the digitizing of our studies and that we continue to ensure that the technologies we deploy are low burden, easy to use, passive and generate data that is meaningful to study participants.